Sarguru Pharmaceuticals Private Limited
About Sarguru Pharmaceuticals Private Limited
Data last updated:
Sarguru Pharmaceuticals Private Limited was a private limited company based in Chennai, Tamil Nadu, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 July 1994.
The company was registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN1994PTC028154.
The company had an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1.2 Lakh. It was led by directors Chellappa Swaminathan (Managing Director) and Guru.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at Plotno4 Bharthicolony Annexurekaikankuppam Chennai – 87.. Kaikankuppam Chennai – 87.., Tamil Nadu, India – 600087.
As per the financials filed for FY 2017, the company reported a revenue of ₹30.17 Lakh, a decline of 36% compared to the previous year. For the same year it recorded a net profit of ₹27,534 (net margin 0.9%) and EBITDA of -₹3.1 Lakh (EBITDA margin -10.3%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years.
Company details
Contact details
Sarguru Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressPlotno4 Bharthicolony Annexurekaikankuppam Chennai – 87.. Kaikankuppam Chennai – 87.., Tamil Nadu, India – 600087
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sarguru Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sarguru Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Sarguru Pharmaceuticals Private Limited
FY 2020 filings availableSarguru Pharmaceuticals Private Limited reported revenue of ₹30.17 Lakh (down 36% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 4% over three years, including a 36% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹30.17 Lakh | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹3.1 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹27,534 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -10.3% | ||
| Net Profit Margin | 0.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Sarguru Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sarguru Pharmaceuticals Private Limited
Sarguru Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Guru Also directs: Sarg Pharmaceuticals Private Limited | Director | 17 Oct 2007 | 19 Years 0 Months | As last reported |
| Chellappa Swaminathan Also directs: Sarg Pharmaceuticals Private Limited | Managing Director | 22 Jul 1994 | 32 Years 3 Months | As last reported |
Auditor
Sarguru Pharmaceuticals Private Limited is audited by S VISHNU & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S VISHNU & CO | FY 2017 | 005179S |
Shareholding
The shareholding of Sarguru Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sarguru Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sarguru Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sarguru Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sarguru Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sarguru Pharmaceuticals Private Limited has 2 board changes on record since 1994: 2 appointments. The latest: Guru was appointed as Director on 17 Oct 2007.
Frequently asked questions
Sarguru Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Sarguru Pharmaceuticals was a private limited company based in Chennai, Tamil Nadu, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 22 July 1994 and is registered under CIN U24231TN1994PTC028154. The company has been struck off by the Registrar of Companies and is no longer operational.
Sarguru Pharmaceuticals had 2 directors:
- Chellappa Swaminathan - Managing Director
- Guru - Director
The CIN (Corporate Identification Number) of Sarguru Pharmaceuticals is U24231TN1994PTC028154. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Sarguru Pharmaceuticals is at Plotno4 Bharthicolony Annexurekaikankuppam Chennai – 87.. Kaikankuppam Chennai – 87.., Tamil Nadu, India – 600087.
Sarguru Pharmaceuticals was incorporated on 22 July 1994. It is registered with the Registrar of Companies, Chennai.
The latest financial statements of Sarguru Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from 2015 are in the company report.
Sarguru Pharmaceuticals operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
Guru was appointed as Director on 17 Oct 2007. Chellappa Swaminathan was appointed as Managing Director on 22 Jul 1994.
The compliance status of Sarguru Pharmaceuticals is compliant as of 16 August 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
